胰腺癌神经周围侵犯严重程度评分的前瞻性预后验证
该前瞻性单中心研究纳入300例接受胰腺切除术的PDAC患者,验证神经周围侵犯(PNI)严重程度评分对复发和生存的预测价值。结果显示PNI 2独立预测复发(HR 2.082,P=0.006)和生存(HR 3.304,P=0.014),且PNI 2患者从辅助治疗中获益最大。
要点
- PNI严重程度评分可改善切除PDAC的预后分层。
- PNI 2独立预测复发和生存,HR分别为2.082和3.304。
- PNI 2患者从辅助治疗中获益最大。
核心结论
- PNI严重程度评分可改善切除PDAC的预后分层,并识别从辅助治疗中获益最大的患者。
研究设计与样本
- 前瞻性注册(NCT04024358)单中心研究,纳入2019年3月至2022年2月接受胰腺切除术的300例患者。
主要发现
- 300例患者中86%存在PNI,其中PNI 1为148例(49.3%),PNI 2为110例(36.7%)。
- 新辅助治疗未影响PNI(89.7% vs. 83.9%,P=0.332)。
- PNI严重程度与病理特征恶化、无病复发时间缩短(PNI 0为24个月,PNI 1为17个月,PNI 2为15个月,P<0.01)和生存期缩短(PNI 0为57个月,PNI 1为51个月,PNI 2为32个月,P<0.01)显著相关。
- PNI 2独立预测复发(HR 2.082,P=0.006)和生存(HR 3.304,P=0.014)。
- PNI 2患者从辅助治疗中获益最大,无病复发时间延长(17 vs. 12个月;P=0.007),生存期延长(36 vs. 17个月;P=0.004)。
临床怎么用
- 对于切除PDAC患者,可采用PNI严重程度评分进行预后分层,PNI 2患者应优先考虑辅助治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to prospectively validate a perineural invasion (PNI) severity score in predicting recurrence and survival in resected PDAC. BACKGROUND: PNI in pancreatic ductal adenocarcinoma (PDAC) is characterized by clinical and morphologic heterogeneity. Although a specific score for PNI severity has been proposed, it lacks validation. METHODS: In this prospective registered (NCT04024358) monocentric study, 300 patients undergoing pancreatectomy between March 2019 and February 2022 were analyzed. PNI was scored as: 0 absent; 1 presence of neoplasia along nerves<3 mm; 2 neoplastic infiltration of nerves≥3 mm and/or massive PNI and/or necrosis of the infiltrated nerves. Association of PNI with disease recurrence and survival was evaluated. RESULTS: Of 300 patients, 86% presented PNI, with 148 (49.3%) having PNI 1 and 110 (36.7%) PNI 2. Neoadjuvant treatment did not influence PNI (89.7% vs. 83.9% after treatment, P=0.332). PNI severity significantly correlated with worsening pathological features, shorter disease recurrence (24 mo for PNI 0, 17 for PNI 1 and 15 for PNI 2, P<0.01) and survival (57 mo for PNI 0, 51 for PNI 1 and 32 for PNI 2, P<0.01). PNI 2 independently predicted both recurrence and survival with HR of 2.082 (P=0.006) and 3.304 (P=0.014). PNI 2 benefitted most from adjuvant treatment, with longer disease recurrence time (17 vs. 12 mo; P=0.007) and survival (36 vs. 17 mo; P=0.004). CONCLUSIONS: The PNI severity score improves prognostic stratification of resected PDAC and identifies patients who benefit the most from adjuvant treatment.
引用
- Gasparini G, Crippa S, Lena MS, et al. Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study. Ann Surg. 2025. PMID: 40856533. doi:10.1097/SLA.0000000000006920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。